Nalaganje...
LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway
INTRODUCTION: Lung adenocarcinoma (LUAD), which is associated with high morbidity and mortality, is prone to cisplatin resistance, resulting in poor patient prognosis. Long non-coding RNAs (lncRNAs) have complex biological functions in a variety of tumors. Elucidating the underlying molecular mechan...
Shranjeno v:
| izdano v: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7090201/ https://ncbi.nlm.nih.gov/pubmed/32256108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S240695 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|